Broker call▼ Bearish for Indian equities
‘Macro overshadowing micro’: Capitalmind AMC expects selling despite decent Q2 results
The brief
- Anoop Vijaykumar expects selling despite decent Q2 results; pharma may remain resilient
- He sees slower recovery for largecap IT and remains cautious on consumption stocks
- Cautious outlook weighs on Indian pharma, IT and consumption stocks despite decent Q2 results
- AI deals seen driving medium-term growth as Indian IT sector faces muted Q2: Report
- Indian IT’s Q2 earnings dilemma deepens: More deals but weaker growth and falling pricing power
- Accenture forecast lifts Indian IT stocks, but investors remain divided on the outlook
- IT firms' Q2 reality check: Growth recovery still out of sight
- IT Q2 preview: Muted growth, steady margins likely; deal conversion, AI deflation under lens